Cardiol Therapeutics Inc. (CRDL) Executive Compensation
Cardiol Therapeutics Inc. (CRDL) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CRDL
CIK: 1702123
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: A6
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
BDO Canada LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerJamie Barron
Audit LocationOakville, Canada
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-09-23 | — | SCHEDULE 13G/A Filing | 0001879713-26-000003 | View SEC Doc Filr Page |
| 6-K | 2026-09-23 | 2026-09-23 | FORM 6-K | 0001279569-26-000905 | View SEC Doc Filr Page |
| SUPPL | 2026-09-16 | — | SUPPL | 0001104659-26-108184 | View SEC Doc Filr Page |
| F-10/A | 2026-09-16 | — | F-10/A | 0001104659-26-108132 | View SEC Doc Filr Page |
| 6-K | 2026-09-16 | 2026-09-16 | FORM 6-K | 0001279569-26-000889 | View SEC Doc Filr Page |
| 6-K | 2026-09-15 | 2026-09-14 | FORM 6-K | 0001104659-26-107594 | View SEC Doc Filr Page |
| 6-K | 2026-09-11 | 2026-09-10 | FORM 6-K | 0001104659-26-106836 | View SEC Doc Filr Page |
| 6-K | 2026-09-10 | 2026-09-10 | FORM 6-K | 0001279569-26-000875 | View SEC Doc Filr Page |
| F-X | 2026-09-10 | — | F-X | 0001104659-26-106651 | View SEC Doc Filr Page |
| F-10 | 2026-09-10 | — | F-10 | 0001104659-26-106628 | View SEC Doc Filr Page |
| 6-K | 2026-09-09 | 2026-09-09 | FORM 6-K | 0001279569-26-000867 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-097122 | View SEC Doc Filr Page |
| 6-K | 2026-08-12 | 2026-06-30 | FORM 6-K | 0001104659-26-094885 | View SEC Doc Filr Page |
| 6-K | 2026-08-05 | 2026-08-05 | FORM 6-K | 0001279569-26-000745 | View SEC Doc Filr Page |
| 6-K | 2026-07-14 | 2026-07-14 | FORM 6-K | 0001279569-26-000670 | View SEC Doc Filr Page |
| 6-K | 2026-07-09 | 2026-07-09 | FORM 6-K | 0001279569-26-000651 | View SEC Doc Filr Page |
| 6-K | 2026-06-25 | 2026-06-25 | FORM 6-K | 0001279569-26-000593 | View SEC Doc Filr Page |
| 6-K | 2026-06-23 | 2026-06-23 | FORM 6-K | 0001279569-26-000575 | View SEC Doc Filr Page |
| 6-K | 2026-05-26 | 2026-05-25 | FORM 6-K | 0001104659-26-066043 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001104659-26-062620 | View SEC Doc Filr Page |
| 6-K | 2026-05-14 | 2026-05-14 | FORM 6-K | 0001279569-26-000442 | View SEC Doc Filr Page |
| 6-K | 2026-05-11 | 2026-03-31 | FORM 6-K | 0001104659-26-058766 | View SEC Doc Filr Page |
| 6-K | 2026-05-07 | 2026-05-07 | FORM 6-K | 0001279569-26-000398 | View SEC Doc Filr Page |
| 6-K | 2026-04-28 | 2026-04-28 | FORM 6-K | 0001279569-26-000353 | View SEC Doc Filr Page |
| 6-K | 2026-04-14 | 2026-04-14 | FORM 6-K | 0001062993-26-001963 | View SEC Doc Filr Page |